immunAware ApS: Financial statements 2021
CVR: 39189135
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
immunAware ApS (CVR 39189135) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 3,427,889 and a net result of DKK 1,182,833 compared with DKK 1,211,357 the year before. That is an increase of 43.1% compared with the year before. Equity in the 2021 report amounted to DKK 3,613,560. The solvency ratio was 86.6%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 3,427,889
- Profit/Loss
- DKK 1,182,833
- Equity
- DKK 3,613,560
- Total Assets
- DKK 4,172,812
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 3.4 mio. | 1.2 mio. | 3.6 mio. | 3 |
| 2020 | - | 2.4 mio. | 1.2 mio. | 2.6 mio. | 1 |
| 2019 | - | 2.3 mio. | 1.4 mio. | 1.5 mio. | 1 |
| 2018 | - | 25 t. | 19 t. | 151 t. | 0 |
Find more companies like immunAware ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
ImmunAware ApS has published its annual report for 2020. Gross profit came to DKK 2,395,210, and the net result was DKK 1,211,357.
About immunAware ApS
immunAware ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Søren Buus, Anette Stryhn Buus and Thomas Østerbye. The company is owned by PROSAL ApS, ASTIM Holding ApS and T.Ø. Holding ApS. In 2025, the company reported a gross profit of DKK 4,626,954 and a net result of DKK -338,581 compared with DKK -757,428 the year before. Equity in the 2025 report amounted to DKK 4,913,587.